An Innovation Roadblock: The Shrinking Availability of Venture Capital in MedTech
Posted January 19, 2018| Prem Meyyan
The medical device sector, like many health segments, is driven by the usual suspects: a growing elderly population, rising prevalence of debilitating diseases, increased importance on quality-of-life, and innovation through painstaking research and development (R&D) efforts.
The latter, the only factor that industry players has any influence over, presents significant potential to cause a paradigm shift in how we approach the treatment and management
of diseases. By extension, innovation, whether in technological hardware or software or other key elements, could drive explosive growth across numerous product segments. What’s the challenge, then? In a word: funding.